Platform Clinical Study for Conquering Scleroderma
Public ClinicalTrials.gov record NCT06195072. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Platform Clinical Study for Conquering Scleroderma: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2b Platform Clinical Study to Evaluate the Safety and Efficacy of Investigational Products in Participants With Interstitial Lung Disease Secondary to Systemic Sclerosis
Study identification
- NCT ID
- NCT06195072
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Scleroderma Research Foundation, Inc.
- Other
- Enrollment
- 400 participants
Conditions and interventions
Interventions
- Amlitelimab Drug
- BI 1015550 (Nerandomilast) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 14, 2024
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
- Last update posted
- Feb 3, 2026
2024 – 2026
United States locations
- U.S. sites
- 34
- U.S. states
- 23
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama - Division of Pulmonary and Critical Care Medicine | Birmingham | Alabama | 35294 | Recruiting |
| Keck School of Medicine at USC Medical Center | Los Angeles | California | 90033 | Recruiting |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | Recruiting |
| University of California, Los Angeles (UCLA) Ronald Reagan Medical Center | Los Angeles | California | 90095-7436 | Withdrawn |
| Stanford University Medical Center | Palo Alto | California | 94305 | Recruiting |
| Yale University School of Medicine - Epilepsy | New Haven | Connecticut | 06520 | Withdrawn |
| Georgetown University Medical Center - Department of Rheumatology | Washington D.C. | District of Columbia | 20007 | Recruiting |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | Recruiting |
| Northwestern University | Chicago | Illinois | 60611 | Recruiting |
| The University of Chicago Medical Center (UCMC) | Chicago | Illinois | 60637 | Recruiting |
| University of Kansas School of Medicine | Kansas City | Kansas | 66160 | Recruiting |
| Johns Hopkins University School of Medicine | Baltimore | Maryland | 21224 | Recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| Boston University (BU) | Boston | Massachusetts | 02215 | Recruiting |
| University of Michigan | Ann Arbor | Michigan | 48109-0370 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55905 | Recruiting |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Withdrawn |
| Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | Recruiting |
| Northwell Health | Great Neck | New York | 11021 | Recruiting |
| Hospital for Special Surgery | New York | New York | 10021 | Recruiting |
| Columbia University Medical Center | New York | New York | 10032 | Recruiting |
| Duke University Medical Center | Durham | North Carolina | 27710 | Recruiting |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Withdrawn |
| Oregon Health & Science University (OHSU) | Portland | Oregon | 97239 | Recruiting |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | Recruiting |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | Withdrawn |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15219 | Withdrawn |
| Medical University of South Carolina (MUSC) | Charleston | South Carolina | 29404 | Recruiting |
| Meharry Medical College | Nashville | Tennessee | 37208 | Withdrawn |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37208 | Not yet recruiting |
| University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics | Houston | Texas | 77030 | Recruiting |
| The University of Utah Health Sciences Center | Salt Lake City | Utah | 84112 | Withdrawn |
| Froedtert Hospital and the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06195072, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 3, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06195072 live on ClinicalTrials.gov.